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GSHRedox homeostasis is essential for basal signaling of several physiological processes, but a unilateral shift towards
an ‘oxidative’ or ‘reductive’ trait will alter intracellular redoxmilieu. Typically, such an event inﬂuences the struc-
ture and the native function of a cell or an organelle. Numerous experimental research and clinical trials over the
last 6 decades have demonstrated that enhanced oxygen-derived free radicals constitute amajor stimulus to trig-
ger damage in several humandiseases, including cardiovascular complications supporting the theory of oxidative
stress (OS). However, until our key discovery, the dynamic interrelationship between “Reductive Stress (RS)” and
cardiac health has been obscured by overwhelming OS studies (Rajasekaran et al., 2007). Notably, this seminal
ﬁnding spurred considerable interest in investigations of other mechanistic insights, and thus far the results
indicate a similar or stronger role for RS, as that of OS. In addition, from our own ﬁndings we strongly believe
that constitutive activation of pathways that enable sustained generation of reducing equivalents of glutathione
(GSH), reduced nicotinamide adenine dinucleotide phosphate (NADPH)will cause RS and impair the basal cellu-
lar signaling mechanisms operating through harmless pro-oxidative events, in turn, disrupting single and/or a
combination of key cellular processes such as growth,maturation, differentiation, survival, death etc., that govern
healthy cell physiology. Here, we have discussed the role of RS as a causal or contributing factor in relevant path-
ophysiology of a major cardiac disease of human origin.
© 2014 Elsevier B.V. All rights reserved.1. Redox homeostasis vs. redox stress
Intracellular stress is known as an abnormal state or a stimulus that
challenges physiological function of an organelle, cell, organ or organ-
ism as a whole. Based on the source and nature, stress exerts physiolog-
ical or pathological consequences. Profound changes in the intracellular
redox milieu are broadly termed as redox stress. Under basal state of
redox milieu known as “redox homeostasis (RH)”, a biological pas de
deux involving oxidants and reductants is essential to regulate many
fundamental biological processes including, but not limited to, cellular
signaling pathways, chromatin remodeling, transcriptional and post-
transcriptional activities, protein folding/conformation, mitochondrial
biogenesis and membrane permeability [1–4]. Thus, interference in
the balance of reactive oxygen species (ROS; oxidants) and reductants
(antioxidants) can dis-equilibrate RH and derange normal cellular lifegnaling Laboratory, Division of
logy, UAB, The University of
Street South, Birmingham, AL
1 205 934 7447.processes. Though ROS and reactive nitrogen species (RNS) candidates,
such as superoxide, hydroxyl radicals, hydrogen peroxide, nitric oxide
and peroxynitrite, are indispensable to support cellular vitality, when
in excess can accumulate oxidative stress (OS), causing oxidation of
lipids, proteins, and DNA, leading to a multitude of pathological condi-
tions including myocardial infarction, vascular abnormality, neurode-
generative diseases and accelerated aging [5–9]. Depending on the
chemistry and concentration of molecules that preserve intracellular
RH, cellular stress can be classiﬁed as (a) oxidative, (b) reductive and
(c) nitrosative. Usually, OS is deﬁned as the shift of balance between cel-
lular oxidative and reductive potential towards oxidative one that are
caused both by excessive generation of highly reactive free radicals
from the mitochondria or other ROS generating sources and an impair-
ment of cytoprotective defense mechanisms that scavenge ROS genera-
tion during normal physiological and/or pathological processes. In
contrast, an increase in reducing equivalents including, but not
restricted to, GSH, NADH, NADPH, and cysteine etc. in conjunction
with immense activation of antioxidant system and suppressed oxida-
tive activity is referred to as reductive stress (RS). In other words, the
imbalance between oxidants and antioxidants in favor of the latter
forms the core of the deﬁnition for “reductive stress”. Typically, RS is
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through a pro-oxidative or optimal-oxidative setting (i.e.) the body's
cytoprotective defense system turning against itself. Since the body's
own defense system itself attacks the system which it is supposed to
shield, we feel that RS could be a potent threat and thus, in a given con-
text, RS could be as deleterious as and/or more deleterious than the OS.
To better understand this concept, an analogy could be drawn as to
what would happen to civilians (cellular system) if the law maker (re-
ductive potential, the cop) turns to a law breaker (stressor). The redox
regulation of cellular response to acute versus chronic stress is illustrat-
ed in Fig. 1.
Over 6 decades of research strongly support that a shift in the redox
state towards OS as one of the leading causes for various pathological
processes and diseases in humans [5,7,8,10–13]. Speciﬁcally, studies
using animals have demonstrated that either activation of enzymes
that generate ROS, such as NADPH oxidases and xanthine oxidase, or in-
hibition of enzymatic pathways counterbalancing ROS production [such
as superoxide dismutase (SOD), catalase, glutathione peroxidase (GPx),
and the thioredoxin/thioredoxin-reductase (Trx/TrxR system)] foster
pathological cardiac remodeling and end-stage heart failure [14]. Never-
theless, the cause and consequences of RS have neither thoroughly beenFig. 1. Cellular ﬁtness associated with redox state. (A) Basal state: Under normal physiol-
ogy, an equilibrium is maintained between the generation of reactive oxygen/nitrogen
species (ROS/RNS) (oxidative species) and counteracting reductant molecules that
quench free radical/oxidant species which are broadly termed as “redox homeostasis
(RH)”. (B) Defensive state: An acute stress stimulus induces intracellular redox signals
evoking compensatory responses which moderately adjusts the concentrations of
oxidants and reductants and helps maintaining a normal physiology. This is a state of
adaptation or acclimation. (C) Stress:When the stress signal is sustained, the redox signal-
ing might go awry and abnormal reﬂecting in loss of compensatory responsiveness
leading to pathological consequences.studied using appropriate in vitro and/or in vivo models, nor reviewed
in the context of human health. Here, we intend to describe the role of
RS in cardio-pathophysiology through analyzing the available reports
since our ﬁrst discovery of reductive stress in a major human cardiac
disease.
2. Reductive stress
RS was ﬁrst introduced by Albert Wendel, to denote the excessive
accumulation of reduced cofactor, NADH that can facilitate reduction
of chelated ferric iron [15–17]. Later, Ghyczy and Boros suggested that
RS could be deﬁned as an abnormal increase in pathological processes
— associated electron pressure or reducing power or high energy reduc-
ing electrons (NADH) accompanied by failure ofmechanisms to quench
the rise in electron pressure [16]. Alternatively, the simplest deﬁnition
for RS could be that a shift of RH with excessive levels of reducing bio-
equivalents. Our laboratory reported a breakthrough ﬁnding that RS
(in the form of increased GSH and NADPH production) coupled with
increased antioxidative pathway enzymes and decreased oxidative
stress biomarkers could be genetically and causally linked to cardiac
hypertrophy and mutant protein aggregation cardiomyopathy [18].
Subsequently, overabundance of reducing power in various experi-
mental models and humans is increasingly linked with several com-
plications, such as lipid membrane damages [19], triacyl glycerol
deposition and mitochondrial stress [20], mitochondrial dysfunction
and cytotoxicity [21], cardiac ischemic injury [22], risk of Alzheimer's dis-
ease [23] and several others.
3. Reductive stress induces protein aggregation cardiomyopathy
It is well known that the equilibrium between molecular duos, such
as the oxidation–reduction ratio of glutathione (GSH/GSSG), nicotin-
amide adenine dinucleotide phosphate (NADPH/NADP) or that of
cysteine to its oxidized form cystine (disulﬁde), tend to regulate var-
ious signaling processes including a number of transcription factors
responsible for controlling redox genes and thereby maintaining in-
tracellular homeostasis [1,24–26]. However, reductant/antioxidative
stress remains to be an under-represented phenomenon in the ﬁelds
of biochemistry and medicine since the cause (for RS) and conse-
quences (of RS) are not familiar. In the recent past, we have found a
transcriptional link that likely provokes or contributes to RS in vivo
and in vitro [18,27]. In a mouse model of human heart disease named
mutant protein aggregation cardiomyopathy (MPAC), we demonstrat-
ed that increased activity of glutathione-6-phosphate dehydrogenase
(G6PD) enhanced the levels of NADPH, a major cofactor/substrate for
multiple enzymes such as glutathione reductase (GSR), NADPH oxi-
dases and nitric oxide synthase (NOS), and GSH, a ubiquitously present
intracellular redox controller. In addition, the exempliﬁed production of
two most abundant antioxidants is linked with activation of antioxida-
tive pathway enzymes such as G6PD, GSR, GPx and catalase further bol-
stering the reductive environment. This oxido-redox shift towards
“reductive side” facilitated a diminution of oxidative stress modiﬁca-
tions of lipids and proteins and all of which were strictly correlated to
protein aggregation related pathophysiology and heart failure [18].
Notably, this clue of toxic gain-of-function mutation causing excessive
reducing equivalents and pathological remodeling of heart may also
reconcile conﬂicting data and unanticipated outcomes from clinical
trials assessing antioxidant therapies in patients with different cardio-
vascular diseases including heart failure. While some of the beneﬁcial
effects of drugs antagonizing the beta-adrenergic and the angioten-
sin II systems have been recognized for their ability to partially
quench ROS [2,14], the direct suppression of ROS-generating enzymes
(i.e. superoxide dismutase, xanthine oxidase etc.) has produced rather
debilitating consequences [28]. This raises an important question as to
whether dysregulation of redox homeostasis towards any extreme
(either reductive or oxidative) condition in a living cell is a biochemical
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are there more intermediates and/or pathways involved in dis-
equilibrating the redox balance towards “reductive side” other than
the mutant protein reported in our study? Thus we strongly believe
that the “reductionist” approaches are expected to deliver a more com-
prehensive understanding to counter the maladaptive protein folding
mechanisms prevailing in human diseases including heart failure, neu-
rodegeneration etc., and thus pressing the need for additional studies
along these lines.
It is important to note that a sole increase in GSH cannot be strictly
referred to as “Reductive Stress”. In our model pertaining to reductive
stress, GSH measurement was used as one of the indices. It was com-
binedwith themeasurement of other duo NADPH/NADP; battery of an-
tioxidant enzymes and oxidative stress markers [18]. In this context,
latest advancements in the chemistry and biology of per- and
polysulﬁes are worth noting. Recent evidences indicate that hydrogen
sulﬁde (H2S), a gasotransmitter, physiologically promotes the forma-
tion of persulﬁde groups and S-sulfhydrates the proteins (i.e. converting
cysteine –SH groups to –SSH). A large number of proteins are shown to
be sulfhydrated both basally as well as in the inducible state in diverse
cell types triggeringperturbations in biological functions [29–32]. A pre-
cise role for polysulﬁdes in critical cellular processes and signal trans-
duction has been documented viz. (i) GAPDH and actin sulfhydration
in liver impairing GAPDH activity and cytoskeletal rearrangements
respectively [30]; (ii) activating transient receptor potential ankyrin 1
(TRPA1) in brain [31] and activation of TRPA1 promote cell cycle pro-
gression and differentiation of cardiac ﬁbroblasts augmenting cardio-
vascular stress [33]; (iii) inhibiting protein tyrosine phosphatase 1B
(PTP1B) thus promoting protein kinase-like endoplasmic reticulum
(ER) kinase (PERK) activity and controlling translation as an ER stress
response [29]; and (iv) sulfhydrating the p65 subunit of NF-κB at
cysteine-38 and augmenting anti-apopotosis gene transcription in
macrophage cultures and liver tissue [32]. Very recently, it has been
demonstrated that endogenous generation of reactive persulﬁdes and
polysulﬁdes could scavenge hydrogen peroxide effectively than GSH
thus endowing antioxidant and cytoprotective functions [34,35]. Thus
any one and/or combination of these polysulﬁde based mechanisms
could also trigger the collapse of cascade of homeostatic signaling
events leading to RS. Future studies warrant the inclusion of per- and
poly-sulﬁde based indices in conjunction with the existing gold stan-
dards to approach and explain the concept of redox based disturbance,
including “reductive stress”.
4. Bio-signature for RS
In a subsequent study, we attempted to build a bio-signature of RS
based on abnormally and differentially expressed genes globally, by
using one of the most effective approaches viz. genomic mining [27].
Primarily, we identiﬁed that genes and/or pathways related to de
novo synthesis and recycling of GSH and NADPH were profoundly
altered at the onset and during the progression of hR120GCryAB cardio-
myopathy, which was consistent with our early ﬁndings [27]. In
addition, we found several genes involved in protein synthesis and
mitochondrial electron transport chain pathways were overexpressed
and downregulated respectively, at both early and late compensatory
stages [27]. The same study also identiﬁed dysregulation of genes in-
volved in targeting cytosolic protein aggregates for degradation when
there is a redox equilibrium tilt towards RS. This is worth noting, since
alterations in components associatedwith folding/aggregation network
could overburden themachinery that governs quality control pathways
conferring either novel or secondary toxic functions that dictate disease
severity. Notably, the endoplasmic reticulum (ER), a key cellular organ-
elle which promotes folding and maturation of proteins operates
uniquely under oxidizing condition compared with the cytosol [36,
37]. In other words, a pro-oxidative setting is a prerequisite for an
efﬁcient ER function and any disturbance (for example: highreductants) would presumably impair the folding and subsequent re-
moval, resulting in extended accrual of unassembled proteins with
marred protein quality and function. This study provided a snapshot
of perturbations at the global genome level and a robust platform for
the understanding of RS in a mutant protein cardiomyopathy model
with respect to aggregation in vivo. Nevertheless, the study is still in
its early days and many fundamental questions need to be addressed.
For example, (a) what is the balance between protein folding and deg-
radation and (b) what are all the cellular compartments that could be
overburdened due to aberrant processing of folded proteins from ER,
which is subsequently disposed by proteolytic events occurring in but
not limited to cytosolic proteasomes, lysosomes, intramembrane sys-
tem and endoplasmic reticulum (ER) in the context of RS [38–41].
5. Causal mechanisms and transcriptional regulation of reductive
stress
In the process of understanding how and why reductive stress
occurs and also to gain insight into the long-term effect of RS, our sub-
sequent research discovered that sustained activation of nuclear
erythroid-2 like factor-2 (Nrf2), transcriptional regulator of antioxidant
genes signiﬁcantly contributes to RS in the TG mouse heart expressing
human mutant CryAB that is associated with protein aggregation car-
diomyopathy (MPAC) [42]. The ﬁndings of this study are summarized
in Fig. 2. A majority of the transcription factors are redox-sensitive and
their dysregulation affects the induction of key targets that might con-
tribute to the pathogenic changes in the intracellular redox milieu. Of
interest, Nrf2, a basic leucine zipper protein, is a redox-sensitive master
transcriptional regulator of several antioxidant genes [43,44]. Under
basal physiological setting, interaction with Keap1 promotes rapid
ubiquitination of Nrf2 and its subsequent proteasome degradation [45,
46]. In response to oxidative/electrophilic stress, Nrf2 dissociates from
Keap1 and translocate to the nucleus and induce transcription of the an-
tioxidant response element (ARE)-containing genes. It has been impli-
cated that Nrf2 protects vital organs from various OS related diseases
such as acute respiratory distress syndrome, pulmonary ﬁbrosis,
hyperoxic injury, hepatocellular necrosis, hepatotoxicity, cancer, and
neuronal dysfunction using in vitro and in vivo Nrf2 knockout models
[47–51]. Thus far, Keap1–Nrf2 interaction is considered to be the prima-
ry regulatory point for the overall response to redox stress, which is also
supported in the cardiovascular system [52,53]. Independent in vitro
studies from our laboratory points out that genetic knock-down of
Keap1, a repressor of Nrf2 function, up-regulates the transcription of
most of the antioxidant genes and thereby constantly upholds the intra-
cellular glutathione (GSH) levels (N2.0 fold), which is likely to cause ‘re-
ductive state’ in an acute setting or ‘reductive stress’ in a chronic
condition in the cardiomyocytes (unpublished data). Thus we believe
that the cardiac pathology/heart failure phenotype is preceded by re-
lentless activation of Nrf2 that is developed in two stages, initially in re-
sponse to ROS generation (~3 months), and later, as a consequence of
Keap1 dysfunction (6 months). This raises an important point as to
how a process that commenced as a reparative signaling response for
mutant protein stress, turned out to be over-compensatory and
“toxic RS” jeopardizing protein turnover of Nrf2. Hypothetically,
oligomerization of the mutant protein and formation of mysterious
aggregates could trigger ROS facilitating the dissociation of the
Keap1–Nrf2 complex. On the other hand, interactions between olig-
omers/aggregates and Keap1 may play a key role in stabilization/ac-
tivation of Nrf2-antioxidant signaling leading to RS in the
hR120GCryAB-TG mouse heart [42].
We also propose othermechanisms for the sustained Nrf2 activation
observed in hR120G cryABmutant model viz. (i) autoregulation of Nrf2
whereinNrf2 can directly bind to its own promoter and keeps activating
it in a positive feedback manner [54]; (ii) a persistent activation of
kinase signaling pathways such as protein kinase C (PKC) and PKR-
like endoplasmic reticulum kinase (PERK) that phosphorylates Nrf2 is
Fig. 2. Transcriptional regulation of reductive stress. Cells in general, respond to oxidative stress by activating Nrf2, a master transcription factor that controls battery of antioxidant genes.
Mutant R120G-CryAB protein mice displayed uncontrolled hyper-activation of Nrf2, with an over-ampliﬁcation of Nrf2-dependent antioxidant genes. Though induction of Nrf2 has been
shown to be promising inmany acutemodels, the sustained and chronic ampliﬁcation of Nrf2 pathway, howeverwas not beneﬁcial but for resulting in damaging hypertrophy. This forms
the unique aspect of ourmodel explaining that a protracted Nrf2 activation could over-compensate for the original stress due to lack of CryAB protein resulting in the observed “reductive
stress”.
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Nrf2–Keap1 association [55,56]; (iii) perturbations in levels and/or
function of Cullin 3 (Cul3), a scaffold protein that forms the E3 ligase
complex with Ring Box1 (Rbx1)-dependent ubiquitin–protein ligase
complex [57,58] thus letting Nrf2 to evade proteasomal degradation
and tilting the balance towards Nrf2; (iv) overproduction of p62 that
can compete with and occupy Nrf2 binding site on Keap1 thus freeing
and stabilizing Nrf2 [59]; (v) a defective and/or compromised ﬁne
tuning mechanism such as microRNA (miR)-mediated gene silencing
of Nrf2 as shown by Narasimhan et al., in non-cardiac cells [60,61]. Cur-
rently studies are underway in our laboratory along these lines to inves-
tigate the reason as to why Nrf2 is activated persistently in hR120G
cryAB reductive stress model.
Typically, the downstream of Nrf2 activation, ARE dependent tran-
scription is also determined by several factors. Particularly, the basic
leucine zipper (bZIP) family of transcription factors viz. Jun, Fos, and
Maf families, widely undergo dimerization (homo and hetero) toactivate or repress gene transcription [62].Withmusculoaponeurotic ﬁ-
brosarcoma oncogene homolog-K (MafK) lacking transactivation do-
main, it must interact with other Mafs, bZIP proteins such as Nrf2 and
Bric-a-Bac, Tramtrack, Broad-complex (BTB) and cap‘n’collar homolog
1 (Bach1) to regulate transcription [63,64]. Nrf2 being one such mem-
ber of bZIP family also readily engages in dimerizing interactions [25,
65]. Typically, during stress Nrf2 is tethered and translocates to nucleus,
heterodimerizes with small maf transcription factors such as MafK.
Complexation of Nrf2 with MafK has been shown to activate target
genes [46]. On the other hand, either homodimerization of small Mafs
or its heterodimerization with Bach1 that contains a transcription
repressing BTB/POZ domain has been shown to inhibit the transcription
of target genes [63,66,67]. In addition, cross talk between Nrf2 and
nuclear factor of kappa light polypeptide gene enhancer in B cells
(NF-κB) under oxidative stress is documented with NF-κB p65 subunit
promoting the recruitment and interaction of histone deacetylase
(HDAC3) with either CREB binding protein (CBP) or MafK causing
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Thus, we believe a sustained Nrf2 activation that is followed by one
or more of these events such as heterodimerization of Bach1-MafK
or homodimerization of small Mafs or p65 dependent HDAC3 recruit-
ment that act as repressors for Nrf2/ARE transcription could presumably
be compromised in the nucleus of hR120GCryAB-TG cardiac tissue lead-
ing to persistent activation of Nrf2/antioxidant pathways [25,65,68]
(Fig. 2). Notably, emerging science indicates that antioxidant supple-
mentation has failed to establish a beneﬁcial effect on cardiovascular
disease morbidity and mortality [69–75]. Thus, research of this kind is
unique in elucidating the conﬂicting dichotomy of too much “oxidant
evil vs antioxidant good” theory further urging the need to employ
appropriatemodel system and expand the understanding of Nrf2 signal-
ing in heart tissue and cardiovascular pathogenesis.
6. Rescue of redox homeostasis prevents reductive stress induced
protein aggregation disease
A deﬁnitive role for Nrf2 in the RS associated hypertrophic process
seen in MPAC mouse model was established recently [42,76] and the
signiﬁcance of this ﬁnding is pictorially represented in Fig. 3. Genetic
manipulation of myocardial Nrf2 levels was achieved by crossing the
hR120GCryAB-TG mice in the Nrf2 knockout background and obtained
transgenicswith reducedNrf2 (Nrf2+/−) levels. The impact of diminu-
tion of Nrf2 on the time-dependent development of hypertrophy in the
context of mutant-CryAB overexpression was scrutinized. Results
indicated that Nrf2 deﬁciency normalized the excessive GSH levels
observed in the TG mice in association with preserved cardiacFig. 3. Limiting reductive stress protects themyocardium. Genetic disruption ofNrf2 and its dimi
and Nrf2-knockout (Nrf2-deﬁcient). The hR120G-CryAB-TG:Nrf2def mice exhibited homeosta
these mice was signiﬁcantly improved with no mortality at the age of 75 weeks when compa
40 weeks. This signiﬁes that sustained Nrf2 activation could hamper the natural cellular adapfunction reﬂecting in retraction of premature death [76]. Moreover,
the insufﬁciency of Nrf2 reduced the expression of genes involved in
GSHmetabolic and antioxidative enzymes, such as glutamate–cysteine
ligase, catalytic subunit (GCLC), glutamate–cysteine ligase, modiﬁer
subunit (GCLM), NAD(P)H dehydrogenase, quinione 1 (NQO1), cata-
lase, G6PD, and GSR, which in turn stiﬂe the RS. These events were
accompanied by reversal of 4-hydroxy-nonenol adducts to basal level,
indicating the loss of redox regulation due to excessive reducingmilieu.
Subsequent to restrained RS, and in the setting of establishing redox
equilibrium in themyocardium, the formation of mutant protein aggre-
gation and over-ubiquitination of proteins was also diminished in all
cardiac fractions of TG:Nrf2+/− mice. In addition, sequestration of
Grp78, the ER-resident chaperone, compromised ER function and
prompted ER stress in TG mice. Interestingly, this effect was partially
rescued in TG:Nrf2+/−mice [76]. Thus the pathological phenotype ob-
served in hR120GCryAB-TG versus the normal phenotype exhibited in
hR120GCryAB-TG x Nrf2-KO crossed mice, indicates that this model
serves as an excellent tool to study the relationship of cardiac hypertro-
phy and “Reductive stress”, a less-studied spectrum of ROS pathology.
The key observations from the transgenic animal model were recapitu-
lated in HL1 cardiomyocytes transfected with mutant-CryAB plasmids.
Overall this study revealed the sinister consequences of overcompensa-
tion by Nrf2 in the context of cardiac remodeling and highlighted the
“double-edged sword” attribute of Nrf2, i.e. protective upon transient
activation in response to stress, but injurious upon persistent activation.
Although trapping of Keap1 by the aggregation of mutant protein
(hR120GCryAB) appears to be crucial for activation of Nrf2 beyond bio-
logical levels, it is obvious that a deﬁnite degree of protein oxidationnution inRSheartswas achieved by intercrossing thehR120G-CryAB-TG (reductive stress)
tic redox state, decreased protein aggregation and delayed cardiac pathology. Survival of
red to 90% of the RS mice exhibited premature sudden cardiac death at the age of
tation further pressing to revisit “oxidants evil/antioxidants angel” theory.
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ing the eminence of redox equilibrium in cellular homeostasis. It is thus
clear, that any effort at inﬂuencing the redox milieu through Nrf2 for
therapeutic purposes will require careful optimization in analyzing
dose dependent effects to prevent destruction. However, this will
need to be preceded by detailed analyses of the regulatorymechanisms
controlling its intracellular levels in cardiac and other systems, which
are underway in our laboratory. Although our claim that Keap1/Nrf2/
ARE pathway could play a vital role in RS is entirely based on partially
understood mechanisms and some preliminary ﬁndings (unpublished
fromour laboratory),we are also certain thatmanypathways and inter-
mediates could fuel RS in cardiac diseases.7. Other studies highlighting the paradoxical outcome of
super-boosting reductive power
In a classical study as early as 1993, it has been demonstrated that
treatment of DTT, a strong reducing agent, led to accumulation of
misfolded proteins in the ER resulting in abnormal regulation of Ire1Fig. 4. Redox switch— cause and consequences. Though the concept of redox based events in t
operates and regulated still remains a work-in-progress. Any type of cell/tissue injury (wound
aging and other unknown risk factors could “switch” on redox signals either temporarily or pe
tinuously is expected to elicit oxidative stress causing vascular inﬂammation, endothelial dysfu
hyper-contractility, impaired electrophysiology and remodeling of cardiomyocytes, atrial ﬁbrill
tation, an uninterrupted supply of “reductive power” is also proven to be deleterious causing i
autophagic response/protein quality control and pathological cardiac remodeling. As illustrat
relation to OS. Bold red triangle indicates changes/alterations.transmembrane kinase/nuclease ultimately leading to aberrant Unfold-
ed Protein Response (UPR) in Saccharomyces cerevisiae [77]. This sug-
gests that induction of reductive state could affect the intracellular
signal transduction pathway mediating homeostatic adaptation to
stress related to ER which might have greater bearing in ER stress
related-disorders such as cardiac diseases, diabetes, neurodegeneration
etc. In another study, Schulz and colleagues reported that treatment of
antioxidants such as N-acetylcysteine (NAC, a precursor of reduced
GSH), abolished the 2-deoxy-D-glucose (2-DG)-induced caloric restric-
tion associated life span extension in Caenorhabditis elegans [78]. Thus,
this study lends further support to the idea that boosting of reducing
power could forestall a beneﬁcial outcome, in this case, lifespan exten-
sion. Contrasting to the widely accepted concept of Hsp induction serv-
ing as a protective mechanism against oxidative stress, Zhang et al. [79]
demonstrated that cardiomyocyte-speciﬁc overexpression of Hsp27 in-
duces reductive stress in the heart that is reﬂected by an increase in the
levels of GSH and GSH-peroxidase along with decreased ROS resulting
in cardiac hypertrophy and reduced lifespan. In addition, they demon-
strated thatHsp-induced cardiomyopathy could be prevented by partial
inhibition of GSH-peroxidase.he biological system is long known, the understanding as to how “redox switch” precisely
ing), pharmacological agents, chronic diseases, genetic predisposition, nutrition, lifestyle,
rmanently. In the context of cardiovascular disease, turning ‘ON’ the oxidative switch con-
nction, impaired nitric oxide (NO) signaling and vascular tone, cardiomyocyte apoptosis,
ation, myocardial infarction, cardiac hypertrophy and heart failure. Contrary to the expec-
mpairment in transcriptional regulation, folding/unfolding of proteins, ER stress response,
ed in the schematic cartoon, the information known for RS is relatively very minimal in
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oxidase (Nox), an important enzyme involved in cellular ROS generation
[22]. In this study, they demonstrated that loss-of-function for Nox4 in a
mouse model displayed altered redox homeostasis with increased
GSH and NADPH and decreased ROS which was associated with
unexpected and poor recovery response to ischemia/reperfusion in-
jury than the gain-of-function Nox4 mouse. Thus, this study clearly
demonstrated that inducing cellular reductive power (by loss-of-
function Nox4 mouse) could greatly compromise the myocardial en-
ergetics and aggravate the cardiac dysfunction during the essential
myocardial-reperfusion management strategies. Studies focusing on
RS in human subjects are emerging. In a recent study, Margaritelis
et al. [80] reported the existence of a wide heterogeneity in exercise-
induced redox response with increased reductive stress instead of the
expected oxidative stress in human subjects. This study suggests that
the individuals who responded with reductive stress after exercise
may not be beneﬁted from exercise to the same extent as that of the
subjects who responded with oxidative stress. In another research
trial with human subjects it has been demonstrated that young and
healthy carriers of Apo ε4 allele suffer from reductive stress. Typically,
carrying an Apo ε4 allele is considered as the major genetic risk factor
for Alzheimer's Disease (AD) and in this context, this new study pro-
vides a key clue that RS could be involved in the progression of AD
[23]. These are some of the classical and relevant studies that highlight
the paradoxical outcome of super-boosting reductants impairing the
signaling mechanisms that depend on physiological level of ROS and
redox-sensitive transcription factors and emphasizing the complexity
of developing therapies that affect the intricately connected redox
states.
8. Conclusions
As a ﬁrm believer of the fact that “Toomuch of anything is not good”,
boosting the biological system with too many reductants may not be a
healthy ﬁx. This is clearly evident from the growing body of scientiﬁc
discoveries that demonstrates the dark side of antioxidant supplemen-
tations [69,70,73–75]. Thus, as scientiﬁc researchers we are convinced
that this would be the right time to revisit the theory of “redox mecha-
nisms” and to investigate if abrogating OS beyond a certain level for an
extended time (chronic) would induce pathological mechanisms, in a
given cell or an organ system, that are uncontrollable. In short, we
need to know “How much is too much” on either side of the spectrum
i.e. howmuch quenching oxidants is beneﬁcial and howmuch boosting
reductants is good? A concise schema of the importance of redox switch
in cardiac pathogenesis is illustrated in Fig. 4. With research into RS still
in its infancy, we emphasize that our RS concepts bear potential for
broad reach within the context of the heart, as cardiomyocytes have a
unique structure and function that can undergo pathological remodel-
ing in response to multiple kinds of stress. Further, arming ourselves
with deepened understanding of the role of RS in pathophysiology
of major cardiac diseases will certainly position us to optimize the
response and effectively manage the myocardial related stress and its
impact on overall cardiac health. From the advancements we have
made thus far in the ﬁeld of RS, we believe that “as much as it is neces-
sary to study the oxidative capacity of the cell, the concept of reductive
power in the context of a pathology should also be viewed as a “bom-
bardier beetle” that when disturbed can spray noxious reactive
chemicals”. Importantly, these scientiﬁc ideas may be consistent in dif-
ferent organ systems in a given context.
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